News

NEWCASTLE UPON TYNE, UK, 10 MARCH 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its SARS-CoV-2 RT -PCR detection assay, has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations…

NEWCASTLE UPON TYNE, UK, 24 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce…

NEWCASTLE UPON TYNE, UK, 22 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its…

NEWCASTLE UPON TYNE, UK, 26 NOVEMBER 2021. QuantuMDx Group Limited (“QuantuMDx”), today confirms that both its SARS-CoV-2 assays for open PCR platforms and its rapid PCR device, Q-POC™, as well as its future respiratory panel (SARS-CoV-2, Flu A, Flu B…